237 related articles for article (PubMed ID: 28237713)
1. Poly - (l) - glutamic acid drug delivery system for the intravesical therapy of bladder cancer using WGA as targeting moiety.
Apfelthaler C; Anzengruber M; Gabor F; Wirth M
Eur J Pharm Biopharm; 2017 Jun; 115():131-139. PubMed ID: 28237713
[TBL] [Abstract][Full Text] [Related]
2. A lectin mediated delivery system for the intravesical treatment of bladder diseases using poly-(L)-glutamic acid as polymeric backbone.
Apfelthaler C; Gassenbauer P; Weisse S; Gabor F; Wirth M
Eur J Pharm Sci; 2018 Jan; 111():376-382. PubMed ID: 29030178
[TBL] [Abstract][Full Text] [Related]
3. A doxorubicin loaded colloidal delivery system for the intravesical therapy of non-muscle invasive bladder cancer using wheat germ agglutinin as targeter.
Apfelthaler C; Skoll K; Ciola R; Gabor F; Wirth M
Eur J Pharm Biopharm; 2018 Sep; 130():177-184. PubMed ID: 29960015
[TBL] [Abstract][Full Text] [Related]
4. Lectin bioconjugates trigger urothelial cytoinvasion--a glycotargeted approach for improved intravesical drug delivery.
Neutsch L; Eggenreich B; Herwig E; Marchetti-Deschmann M; Allmaier G; Gabor F; Wirth M
Eur J Pharm Biopharm; 2012 Oct; 82(2):367-75. PubMed ID: 22889683
[TBL] [Abstract][Full Text] [Related]
5. Glycan-mediated uptake in urothelial primary cells: Perspectives for improved intravesical drug delivery in urinary tract infections.
Pichl CM; Feilhauer S; Schwaigerlehner RM; Gabor F; Wirth M; Neutsch L
Int J Pharm; 2015 Nov; 495(2):710-8. PubMed ID: 26383837
[TBL] [Abstract][Full Text] [Related]
6. Lectin mediated biorecognition as a novel strategy for targeted delivery to bladder cancer.
Neutsch L; Plattner VE; Polster-Wildhofen S; Zidar A; Chott A; Borchard G; Zechner O; Gabor F; Wirth M
J Urol; 2011 Oct; 186(4):1481-8. PubMed ID: 21855917
[TBL] [Abstract][Full Text] [Related]
7. Biomimetic delivery strategies at the urothelium: targeted cytoinvasion in bladder cancer cells via lectin bioconjugates.
Neutsch L; Eggenreich B; Herwig E; Marchetti-Deschmann M; Allmaier G; Gabor F; Wirth M
Pharm Res; 2014 Mar; 31(3):819-32. PubMed ID: 24366662
[TBL] [Abstract][Full Text] [Related]
8. UPEC biomimickry at the urothelial barrier: lectin-functionalized PLGA microparticles for improved intravesical chemotherapy.
Neutsch L; Wambacher M; Wirth EM; Spijker S; Kählig H; Wirth M; Gabor F
Int J Pharm; 2013 Jun; 450(1-2):163-76. PubMed ID: 23628404
[TBL] [Abstract][Full Text] [Related]
9. Targeted drug delivery: binding and uptake of plant lectins using human 5637 bladder cancer cells.
Plattner VE; Wagner M; Ratzinger G; Gabor F; Wirth M
Eur J Pharm Biopharm; 2008 Oct; 70(2):572-6. PubMed ID: 18602465
[TBL] [Abstract][Full Text] [Related]
10. Synergistic targeting/prodrug strategies for intravesical drug delivery--lectin-modified PLGA microparticles enhance cytotoxicity of stearoyl gemcitabine by contact-dependent transfer.
Neutsch L; Wirth EM; Spijker S; Pichl C; Kählig H; Gabor F; Wirth M
J Control Release; 2013 Jul; 169(1-2):62-72. PubMed ID: 23588390
[TBL] [Abstract][Full Text] [Related]
11. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.
GuhaSarkar S; Banerjee R
J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887
[TBL] [Abstract][Full Text] [Related]
12. Lectin-mediated drug delivery: binding and uptake of BSA-WGA conjugates using the Caco-2 model.
Gabor F; Schwarzbauer A; Wirth M
Int J Pharm; 2002 Apr; 237(1-2):227-39. PubMed ID: 11955820
[TBL] [Abstract][Full Text] [Related]
13. Lectin-mediated bioadhesion: preparation, stability and caco-2 binding of wheat germ agglutinin-functionalized Poly(D,L-lactic-co-glycolic acid)-microspheres.
Ertl B; Heigl F; Wirth M; Gabor F
J Drug Target; 2000; 8(3):173-84. PubMed ID: 10938527
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery.
Makhlof A; Fujimoto S; Tozuka Y; Takeuchi H
Eur J Pharm Biopharm; 2011 Feb; 77(2):216-24. PubMed ID: 21147220
[TBL] [Abstract][Full Text] [Related]
15. LogP of N-acyl-gemcitabine and lectin-corona emerge as key parameters in nanoparticulate intravesical cancer therapy.
Anzengruber M; Wimmer L; Szuchar R; Skoll K; Wirth M; Gabor F
Eur J Pharm Sci; 2023 Jan; 180():106330. PubMed ID: 36379358
[TBL] [Abstract][Full Text] [Related]
16. Targeted systemic mesenchymal stem cell delivery using hyaluronate - wheat germ agglutinin conjugate.
Kim YS; Kong WH; Kim H; Hahn SK
Biomaterials; 2016 Nov; 106():217-27. PubMed ID: 27569867
[TBL] [Abstract][Full Text] [Related]
17. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration.
Gao X; Tao W; Lu W; Zhang Q; Zhang Y; Jiang X; Fu S
Biomaterials; 2006 Jun; 27(18):3482-90. PubMed ID: 16510178
[TBL] [Abstract][Full Text] [Related]
18. Functionalisation of allergen-loaded microspheres with wheat germ agglutinin for targeting enterocytes.
Walter F; Schöll I; Untersmayr E; Ellinger A; Boltz-Nitulescu G; Scheiner O; Gabor F; Jensen-Jarolim E
Biochem Biophys Res Commun; 2004 Mar; 315(2):281-7. PubMed ID: 14766205
[TBL] [Abstract][Full Text] [Related]
19. Wheat germ agglutinin-grafted lipid nanoparticles: preparation and in vitro evaluation of the association with Caco-2 monolayers.
Liu Y; Wang P; Sun C; Feng N; Zhou W; Yang Y; Tan R; Chen Z; Wu S; Zhao J
Int J Pharm; 2010 Sep; 397(1-2):155-63. PubMed ID: 20599600
[TBL] [Abstract][Full Text] [Related]
20. Fluorinated Polymer Mediated Transmucosal Peptide Delivery for Intravesical Instillation Therapy of Bladder Cancer.
Li G; Lei Q; Wang F; Deng D; Wang S; Tian L; Shen W; Cheng Y; Liu Z; Wu S
Small; 2019 Jun; 15(25):e1900936. PubMed ID: 31074941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
